NAD and Aging

Mark discusses the decline of NAD levels during aging and the role of CD38 in this process. He emphasizes the need for innovative solutions, such as small molecule inhibitors of CD38, rather than merely supplementing with NAD precursors. This approach could potentially lead to more effective strategies for combating age-related energy deficits and improving lifespan.